Alveus Therapeutics Inc

📍 Philadelphia, United States🗓 Founded 2023👥 30 employees💰 Last funded Feb 2026
Biotechnology Research🌐 alveustx.com
Website LinkedIn
Alveus Therapeutics is a clinical-stage biotechnology company developing next-generation therapies for obesity and metabolic diseases, designed for sustained efficacy, improved tolerability, and reduced treatment burden.
3
Total investors
1
Early stage
2
Mid stage
0
Late stage
2023
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Italy
1
Investor activity2023–2026 · investors recorded per year
2023120262
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Alveus Therapeutics Inc?
Alveus Therapeutics Inc has 3 investors on record on gritt.io, including 1 early-stage backers, 2 mid-stage.
When did Alveus Therapeutics Inc last raise funding?
The most recent investment in Alveus Therapeutics Inc recorded on gritt.io was in February 2026.
When was Alveus Therapeutics Inc founded?
Alveus Therapeutics Inc was founded in 2023.
What industry is Alveus Therapeutics Inc in?
Alveus Therapeutics Inc operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Alveus Therapeutics Inc based?
Alveus Therapeutics Inc is headquartered in Philadelphia, United States.